Medical Aesthetics Market - Global Outlook & Forecast 2022-2027
Description
Medical Aesthetics Market - Global Outlook & Forecast 2022-2027
The global medical aesthetics market is expected to grow at a CAGR of 13.71% during 2022-2027.
MARKET INSIGHTS
The global medical aesthetics market trends include consumers seeking aesthetic procedures starting at a younger age, an uptick in men seeking cosmetic enhancement procedures, and an increasing preference for non-invasive cosmetic procedures instead of cosmetic surgery. The market is witnessing the launch of many advanced and innovative devices and products from global, regional, and local vendors. Facelifts, liposuction, botox & neuromodulators, skin resurfacing, and intense pulse light procedures are witnessing high demand from various age groups.
Medical aesthetics treatment focuses on treating and improving the appearance of the patient skin & body. Medical aesthetics treatments are not as aggressive as surgical interventions; they include minimally invasive and non-invasive surgical procedures that enhance the body shape, skin texture, and other benefits. It required high skills, knowledge, and training in human anatomy and physiology. The global medical aesthetics industry has changed in the past few years, with the overall demand for cosmetic treatments trending in a single direction; on another side despite the barriers and restrictions on cosmetic procedures significantly imposed by the COVID-19 pandemic, there was still a healthy rise of 3% from 2019. This reveals that the preference for improving appearance is strong, and there are enormous opportunities for the medical aesthetics market in the coming years.
New Medical Aesthetics Launched in the Medical Aesthetics Market
The advancement in medical aesthetics procedures will expect to achieve significant market growth. The medical aesthetics market is overgrowing with aesthetic dermatology sectors, including innovations in botanical blends in hair care, skincare, and others. The procedures, methodologies, and systems applied for dermatology procedures in the past were completely different from recent years. The significant changes in dermatology care and advancement in technology in skincare and medical aesthetics paved the direction for innumerable procedures that reduced the side effects. Laser applications are highly adopted for treating gentle vascular birthmarks, haemangioma, and other skin issues.
MARKET TRENDS & OPPORTUNITIES
The Surge in Demand for Minimally Invasive & Non-invasive Aesthetic Procedures
INSIGHTS BY PROCEDURE
The medical aesthetics market by procedure type includes non-invasive and minimally invasive cosmetic procedures aimed at improving the physical appearance and satisfaction of the target patient. The minimally invasive procedure segment accounts for 57.14% highest market share, and non-invasive procedures account for 42.86% market share in 2021. Minimally invasive and non-invasive aesthetic procedures are trending and widely accepted globally, owing to fewer surgical interventions, low downtime, less pain, and high safety/efficacy.
Segmentation by Procedures
The global medical aesthetics market by product type is dominated by the body contouring devices segment and accounts for a 27.38% market share. The market is by product type segments into body contouring devices, laser & energy-based devices, cosmetic implants, derma fillers & neuromodulators, micro-needling & chemical peels, microdermabrasion, and others (thread lift and skin lighteners). The increasing number of minimally invasive medical aesthetic procedures drive the segmental growth to reduce fat and body shaping and accelerate the higher segmental growth in 2021. Behind body countering devices, lased and energy-based devices accounted for a 21.86% market share and indicated rapid industry growth.
Segmentation by Product
Body contouring & cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, and others are the key segments by application in the global medical aesthetic market. In which body contouring & cellulite reduction application segment accounted for a 30.58% market share. The increasing demand for fat reduction, cellulite reduction, and liposuction procedures drives segmental growth. Skin tighteners and resurfacing are also becoming more popular in recent years, which is expected to achieve significant growth in the upcoming time.
Segmentation by Application
The global medical aesthetics market is segmented into hospitals & skin clinics, medical spas & beauty centers, and homecare on end-users basics. In 2021, hospitals and skin clinics accounted for a 55.24% market share, dominating the other segments. The increasing demand for minimally invasive and non-invasive procedures and rising awareness drive the high hospital visits and fuel segmental growth. Also, medical aesthetic treatments show easily accessible and deliverable advancements in hospitals and clinics, which drives segmental growth.
Segmentation by End-Users
North America dominates the global medical aesthetics market and is expected to grow with a CAGR of 12.52% during the forecast period. The factors that propel the market growth in the region are the higher expenditure on medical aesthetic procedures, well-established healthcare infrastructure, and access to medical aesthetic procedures. In North America, the U.S. is a well-developed country that solely drives significant industry growth. In the U.S., liposuction, breast augmentation, and tummy tuck medical aesthetic procedures are in high demand.
Among all regions, APAC is expected to grow faster, with a CAGR of around 15% during the forecast period. The rising aging population, the increasing acceptance and demand for cosmetic surgeries, and expenditure on medical aesthetic procedures show significant market growth opportunities in the region. In addition, the growing access to medical aesthetic procedures in Japan, China, India, South Korea, and Australia shows significant improvement.
Segmentation by Geography
The global medical aesthetics market is highly competitive and dynamic, with many international, regional, and local vendors offering a diverse range of medical aesthetic procedure products, treatments, and devices to the end-user. Global players such as AbbVie (Allergan), Sisram Medical, Cutera Inc., Lumenis Inc., Bausch & Lomb, and El En Spa are some of the primary industry players that consistently influence the competition in the industry.
Based on geography, most industry players are headquartered in the U.S., Japan, European Region, and APAC region. One of the U.S.-based companies, AbbVie leading industry player in the medical aesthetics market with a broad spectrum of innovative and advanced solutions for solving serious health issues. In 2021, AbbVie acquired Allergan, the leading company in the medical aesthetics market. This acquisition creates a new product portfolio in AbbVie's product portfolio. Also, the highly demanded and popular Botox comes under the AbbVie product category. Botox individually influences high competition in the industry.
Key Vendors
1. What is the size of the global medical aesthetics market?
2. What is the global medical aesthetics market growth?
3. What are the trends in the global medical aesthetics market?
4. Who are the key players in the global medical aesthetics market?
5. Which region will dominate the global medical aesthetics market share?
The global medical aesthetics market is expected to grow at a CAGR of 13.71% during 2022-2027.
MARKET INSIGHTS
The global medical aesthetics market trends include consumers seeking aesthetic procedures starting at a younger age, an uptick in men seeking cosmetic enhancement procedures, and an increasing preference for non-invasive cosmetic procedures instead of cosmetic surgery. The market is witnessing the launch of many advanced and innovative devices and products from global, regional, and local vendors. Facelifts, liposuction, botox & neuromodulators, skin resurfacing, and intense pulse light procedures are witnessing high demand from various age groups.
Medical aesthetics treatment focuses on treating and improving the appearance of the patient skin & body. Medical aesthetics treatments are not as aggressive as surgical interventions; they include minimally invasive and non-invasive surgical procedures that enhance the body shape, skin texture, and other benefits. It required high skills, knowledge, and training in human anatomy and physiology. The global medical aesthetics industry has changed in the past few years, with the overall demand for cosmetic treatments trending in a single direction; on another side despite the barriers and restrictions on cosmetic procedures significantly imposed by the COVID-19 pandemic, there was still a healthy rise of 3% from 2019. This reveals that the preference for improving appearance is strong, and there are enormous opportunities for the medical aesthetics market in the coming years.
New Medical Aesthetics Launched in the Medical Aesthetics Market
- In 2022, newly launched treatment such as Ellacor dermal micro-coring is becoming more popular for lines and laxity.
- A newly developed treatment RHA Redensity is used for lip lines. RHA Redensity gets approval for the correction of moderate and severe lip lines.
- In 2022, a new thread lift, “APTOS, was launched. The Aptos PLLA/PCL treads are developed from a novel blend of polymer material. These threads have good tissue gripping strengths with longer-lasting results.
- The new glow-boosting injectable “Volite” is more akin to that of a laser for enhancing skin quality, tone, and texture.
- The newly developed Sculptra for cellulite is collagen stimulating injectables indication used off-label for many years for the augmentation of the buttocks wrap up with clinical trials expected in 2022.
- The breast-enhancing implant A Cleavage will be available for patient use in 2022.
The advancement in medical aesthetics procedures will expect to achieve significant market growth. The medical aesthetics market is overgrowing with aesthetic dermatology sectors, including innovations in botanical blends in hair care, skincare, and others. The procedures, methodologies, and systems applied for dermatology procedures in the past were completely different from recent years. The significant changes in dermatology care and advancement in technology in skincare and medical aesthetics paved the direction for innumerable procedures that reduced the side effects. Laser applications are highly adopted for treating gentle vascular birthmarks, haemangioma, and other skin issues.
MARKET TRENDS & OPPORTUNITIES
The Surge in Demand for Minimally Invasive & Non-invasive Aesthetic Procedures
- The demand for minimally invasive procedures increased significantly in recent years across all demographics. In addition, non-invasive treatments are a more accessible entry point in the medical aesthetic market for men and young people who are highly curious about their appearance and well-known about medical aesthetics. It indicated that the non-invasive procedures are a good fit for many consumers due to their affordable cost, low downtime, and lower risk.
- Over the decade, the rising awareness about medical aesthetic solutions and increasing expenditure on personal care/cosmeceutical significantly induced medical aesthetics market growth. In 2022, the Aesthetic Society report revealed that the increasing expense for aesthetic solutions had given high market growth in recent years. People spent approximately USD 9.3 billion on aesthetic procedures in 2020. Of that, around USD 3 billion was registered for non-invasive treatment and USD 6 billion for invasive treatments. From 2019 to 2020, the expenditure for aesthetic procedures increased to almost 80%. In 2019, approximately USD 8.2 billion was spent on aesthetic procedures. This significant growth shows the rising expenditure and awareness about medical aesthetic procedures.
- The youth and aging population are the primary users of medical aesthetics treatment. These treatments to combat aging have emerged from anti-aging creams to approved cosmetic procedures. Currently, more and more young population are turning to cosmetic and aesthetic procedures to prevent their bodies from aging.
- Medical tourism is expanding globally, with patients seeking cosmetic surgery abroad. The changes caused by the globalization of medical services, the shift of lifestyle with displaying a healthy lifestyle, attention to the figure, and well-being associated with external appearance, combined with the willingness to travel, have given rise to a new segment of health tourism, that is aesthetic medicine tourism.
INSIGHTS BY PROCEDURE
The medical aesthetics market by procedure type includes non-invasive and minimally invasive cosmetic procedures aimed at improving the physical appearance and satisfaction of the target patient. The minimally invasive procedure segment accounts for 57.14% highest market share, and non-invasive procedures account for 42.86% market share in 2021. Minimally invasive and non-invasive aesthetic procedures are trending and widely accepted globally, owing to fewer surgical interventions, low downtime, less pain, and high safety/efficacy.
Segmentation by Procedures
- Minimally Invasive
- Non-Invasive
The global medical aesthetics market by product type is dominated by the body contouring devices segment and accounts for a 27.38% market share. The market is by product type segments into body contouring devices, laser & energy-based devices, cosmetic implants, derma fillers & neuromodulators, micro-needling & chemical peels, microdermabrasion, and others (thread lift and skin lighteners). The increasing number of minimally invasive medical aesthetic procedures drive the segmental growth to reduce fat and body shaping and accelerate the higher segmental growth in 2021. Behind body countering devices, lased and energy-based devices accounted for a 21.86% market share and indicated rapid industry growth.
Segmentation by Product
- Body Contouring Devices
- Laser & Energy Based Devices
- Cosmetic Implants
- Derma Filler & Neuromodulators
- Microneedling & Chemical Peels
- Microdermabrasion
- Other
Body contouring & cellulite reduction, skin tightening and resurfacing, facial aesthetics, breast augmentation, and others are the key segments by application in the global medical aesthetic market. In which body contouring & cellulite reduction application segment accounted for a 30.58% market share. The increasing demand for fat reduction, cellulite reduction, and liposuction procedures drives segmental growth. Skin tighteners and resurfacing are also becoming more popular in recent years, which is expected to achieve significant growth in the upcoming time.
Segmentation by Application
- Body Contouring & Cellulite Reduction
- Skin Tightening & Skin Lighteners
- Facial Aesthetic
- Breast Augmentation
- Others
The global medical aesthetics market is segmented into hospitals & skin clinics, medical spas & beauty centers, and homecare on end-users basics. In 2021, hospitals and skin clinics accounted for a 55.24% market share, dominating the other segments. The increasing demand for minimally invasive and non-invasive procedures and rising awareness drive the high hospital visits and fuel segmental growth. Also, medical aesthetic treatments show easily accessible and deliverable advancements in hospitals and clinics, which drives segmental growth.
Segmentation by End-Users
- Hospital & Skin Clinics
- Medical Spa & Beauty Centres
- Homecare
North America dominates the global medical aesthetics market and is expected to grow with a CAGR of 12.52% during the forecast period. The factors that propel the market growth in the region are the higher expenditure on medical aesthetic procedures, well-established healthcare infrastructure, and access to medical aesthetic procedures. In North America, the U.S. is a well-developed country that solely drives significant industry growth. In the U.S., liposuction, breast augmentation, and tummy tuck medical aesthetic procedures are in high demand.
Among all regions, APAC is expected to grow faster, with a CAGR of around 15% during the forecast period. The rising aging population, the increasing acceptance and demand for cosmetic surgeries, and expenditure on medical aesthetic procedures show significant market growth opportunities in the region. In addition, the growing access to medical aesthetic procedures in Japan, China, India, South Korea, and Australia shows significant improvement.
Segmentation by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- APAC
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
The global medical aesthetics market is highly competitive and dynamic, with many international, regional, and local vendors offering a diverse range of medical aesthetic procedure products, treatments, and devices to the end-user. Global players such as AbbVie (Allergan), Sisram Medical, Cutera Inc., Lumenis Inc., Bausch & Lomb, and El En Spa are some of the primary industry players that consistently influence the competition in the industry.
Based on geography, most industry players are headquartered in the U.S., Japan, European Region, and APAC region. One of the U.S.-based companies, AbbVie leading industry player in the medical aesthetics market with a broad spectrum of innovative and advanced solutions for solving serious health issues. In 2021, AbbVie acquired Allergan, the leading company in the medical aesthetics market. This acquisition creates a new product portfolio in AbbVie's product portfolio. Also, the highly demanded and popular Botox comes under the AbbVie product category. Botox individually influences high competition in the industry.
Key Vendors
- AbbVie (Allergan)
- Bausch Health Companies
- Candela
- Cutera
- Cynosure
- EL.En. S.p.A.
- Galderma
- Johnson & Johnson
- Lumenis
- Merz Pharma
- Sientra
- Sinclair
- Sisram Medical
- Aerolase
- Aesthetics Biomedical
- Asclepion Laser Technologies
- Astanza Laser
- Beijing Sanhe Beauty S & T Co.
- Beijing ADSS Development
- Biolitec
- Biotec Italia
- BISON Medical
- Bluecore Company
- Brera Medical Technologies S.R.L.
- BTL Aesthetics
- Cartessa Aesthetics
- Dominion Aesthetic Technologies
- Erchonia
- ENDYMED
- F Care Systems
- Gigaalaser
- GSD - Global Skin Dermatologist
- InMode Aesthetic Solutions
- Leaflife Technology
- LINLINE Medical Systems
- Lutronic
- Lynton Lasers
- MedArt ApS
- Microaire Surgical Instruments
- Medytox
- Meyer-Haake
- PhotoMedex
- Revance Aesthetics
- Sciton
- ThermiGen
- Venus Concept
- Wavemed
- Zimmer MedizinSysteme
1. What is the size of the global medical aesthetics market?
2. What is the global medical aesthetics market growth?
3. What are the trends in the global medical aesthetics market?
4. Who are the key players in the global medical aesthetics market?
5. Which region will dominate the global medical aesthetics market share?
Table of Contents
354 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 OVERVIEW
- 8 PREMIUM INSIGHTS
- 8.1 OVERVIEW
- 8.1.1 MEDICAL AESTHETICS MARKET SCENARIO
- 8.1.2 MEDICAL AESTHETICS MARKET SEGMENTATION
- 9 MARKET OPPORTUNITIES & TRENDS
- 9.1 APPLICATION OF PLATELET-RICH PLASMA (PRP) IN MEDICAL AESTHETICS
- 9.2 ADVANCES IN MEDICAL AESTHETICS
- 9.3 LAUNCH OF NEW MEDICAL AESTHETIC TREATMENTS
- 10 MARKET GROWTH ENABLERS
- 10.1 BETTER ACCESS TO COSMETIC SURGERIES THROUGH MEDICAL TOURISM
- 10.2 INCREASING EXPENDITURE ON MEDICAL AESTHETIC PROCEDURES
- 10.3 RISE IN DEMAND FOR MINIMALLY INVASIVE & NON-INVASIVE SURGERIES
- 10.4 AGING DEMOGRAPHIC COHORTS & INCREASING FOCUS ON IMPROVING APPEARANCE
- 11 MARKET RESTRAINTS
- 11.1 SIDE EFFECTS ASSOCIATED WITH MEDICAL AESTHETIC TREATMENTS
- 11.2 HIGH COSTS ASSOCIATED WITH MEDICAL AESTHETIC TREATMENTS
- 12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.2 MARKET SIZE & FORECAST
- 12.2.1 GEOGRAPHY INSIGHTS
- 12.2.2 PROCEDURE INSIGHTS
- 12.2.3 PRODUCT INSIGHTS
- 12.2.4 APPLICATION INSIGHTS
- 12.2.5 END-USER INSIGHTS
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
- 13 PROCEDURES
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 MINIMALLY INVASIVE MEDICAL AESTHETICS
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 NON-INVASIVE MEDICAL AESTHETICS
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 14 PRODUCT
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 BODY CONTOURING DEVICES
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 LASER & ENERGY BASED DEVICES
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
- 14.5 COSMETIC IMPLANTS
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
- 14.6 DERMAL FILLERS & NEUROMODULATORS
- 14.6.1 MARKET OVERVIEW
- 14.6.2 MARKET SIZE & FORECAST
- 14.6.3 MARKET BY GEOGRAPHY
- 14.7 MICRONEEDLING & CHEMICAL PEELS
- 14.7.1 MARKET OVERVIEW
- 14.7.2 MARKET SIZE & FORECAST
- 14.7.3 MARKET BY GEOGRAPHY
- 14.8 MICRODERMABRASION
- 14.8.1 MARKET OVERVIEW
- 14.8.2 MARKET SIZE & FORECAST
- 14.8.3 MARKET BY GEOGRAPHY
- 14.9 OTHERS
- 14.9.1 MARKET OVERVIEW
- 14.9.2 MARKET SIZE & FORECAST
- 14.9.3 MARKET BY GEOGRAPHY
- 15 APPLICATION
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 BODY CONTOURING & CELLULITE REDUCTION
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 MARKET BY GEOGRAPHY
- 15.4 SKIN TIGHTENING & RESURFACING
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 MARKET BY GEOGRAPHY
- 15.5 FACIAL AESTHETICS
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
- 15.5.3 MARKET BY GEOGRAPHY
- 15.6 BREAST AUGMENTATION
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST
- 15.6.3 MARKET BY GEOGRAPHY
- 15.7 OTHERS
- 15.7.1 MARKET OVERVIEW
- 15.7.2 MARKET SIZE & FORECAST
- 15.7.3 MARKET BY GEOGRAPHY
- 16 END USER
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 MARKET OVERVIEW
- 16.3 HOSPITALS & SKIN CLINICS
- 16.3.1 MARKET OVERVIEW
- 16.3.2 MARKET SIZE & FORECAST
- 16.3.3 MARKET BY GEOGRAPHY
- 16.4 MEDICAL SPAS & BEAUTY CENTERS
- 16.4.1 MARKET OVERVIEW
- 16.4.2 MARKET SIZE & FORECAST
- 16.4.3 MARKET BY GEOGRAPHY
- 16.5 HOMECARE
- 16.5.1 MARKET OVERVIEW
- 16.5.2 MARKET SIZE & FORECAST
- 16.5.3 MARKET BY GEOGRAPHY
- 17 GEOGRAPHY
- 17.1 MARKET SNAPSHOT & GROWTH ENGINE
- 17.2 GEOGRAPHIC OVERVIEW
- 18 NORTH AMERICA
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 PROCEDURE
- 18.3.1 MARKET SIZE & FORECAST
- 18.4 PRODUCT
- 18.4.1 MARKET SIZE & FORECAST
- 18.5 APPLICATION
- 18.5.1 MARKET SIZE & FORECAST
- 18.6 END USER
- 18.6.1 MARKET SIZE & FORECAST
- 18.7 KEY COUNTRIES
- 18.7.1 US: MARKET SIZE & FORECAST
- 18.7.2 CANADA: MARKET SIZE & FORECAST
- 19 EUROPE
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 PROCEDURE
- 19.3.1 MARKET SIZE & FORECAST
- 19.4 PRODUCT
- 19.4.1 MARKET SIZE & FORECAST
- 19.5 APPLICATION
- 19.5.1 MARKET SIZE & FORECAST
- 19.6 END USER
- 19.6.1 MARKET SIZE & FORECAST
- 19.7 KEY COUNTRIES
- 19.7.1 GERMANY: MARKET SIZE & FORECAST
- 19.7.2 UK: MARKET SIZE & FORECAST
- 19.7.3 ITALY: MARKET SIZE & FORECAST
- 19.7.4 SPAIN: MARKET SIZE & FORECAST
- 19.7.5 FRANCE: MARKET SIZE & FORECAST
- 20 APAC
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 PROCEDURE
- 20.3.1 MARKET SIZE & FORECAST
- 20.4 PRODUCT
- 20.4.1 MARKET SIZE & FORECAST
- 20.5 APPLICATION
- 20.5.1 MARKET SIZE & FORECAST
- 20.6 END USER
- 20.6.1 MARKET SIZE & FORECAST
- 20.7 KEY COUNTRIES
- 20.7.1 CHINA: MARKET SIZE & FORECAST
- 20.7.2 JAPAN: MARKET SIZE & FORECAST
- 20.7.3 INDIA: MARKET OVERVIEW
- 20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 20.7.5 AUSTRALIA: MARKET OVERVIEW
- 21 LATIN AMERICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.3 PROCEDURE
- 21.3.1 MARKET SIZE & FORECAST
- 21.4 PRODUCT
- 21.4.1 MARKET SIZE & FORECAST
- 21.5 APPLICATION
- 21.5.1 MARKET SIZE & FORECAST
- 21.6 END USER
- 21.6.1 MARKET SIZE & FORECAST
- 21.7 KEY COUNTRIES
- 21.7.1 BRAZIL: MARKET SIZE & FORECAST
- 21.7.2 MEXICO: MARKET SIZE & FORECAST
- 21.7.3 ARGENTINA: MARKET SIZE & FORECAST
- 22 MIDDLE EAST & AFRICA
- 22.1 MARKET OVERVIEW
- 22.2 MARKET SIZE & FORECAST
- 22.3 PROCEDURE
- 22.3.1 MARKET SIZE & FORECAST
- 22.4 PRODUCT
- 22.4.1 MARKET SIZE & FORECAST
- 22.5 APPLICATION
- 22.5.1 MARKET SIZE & FORECAST
- 22.6 END USER
- 22.6.1 MARKET SIZE & FORECAST
- 22.7 KEY COUNTRIES
- 22.7.1 TURKEY: MARKET SIZE & FORECAST
- 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
- 23 COMPETITIVE LANDSCAPE
- 23.1 COMPETITION OVERVIEW
- 23.2 MARKET SHARE ANALYSIS
- 23.2.1 ABBVIE
- 23.2.2 BAUSCH HEALTH COMPANIES
- 23.2.3 CANDELA
- 23.2.4 CUTERA
- 23.2.5 CYNOSURE
- 23.2.6 EL.EN. S.P.A.
- 23.2.7 LUMENIS
- 23.2.8 MERZ PHARMA
- 23.2.9 SISRAM MEDICAL
- 24 KEY COMPANY PROFILES
- 24.1 ABBVIE (ALLERGAN)
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
- 24.1.3 KEY STRATEGIES
- 24.1.4 KEY STRENGTHS
- 24.1.5 KEY OPPORTUNITIES
- 24.2 BAUSCH HEALTH COMPANIES
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
- 24.2.3 KEY STRATEGIES
- 24.2.4 KEY STRENGTHS
- 24.2.5 KEY OPPORTUNITIES
- 24.3 CANDELA
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
- 24.3.3 KEY STRATEGIES
- 24.3.4 KEY STRENGTHS
- 24.3.5 KEY OPPORTUNITIES
- 24.4 CUTERA
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
- 24.4.3 KEY STRATEGIES
- 24.4.4 KEY STRENGTHS
- 24.4.5 KEY OPPORTUNITIES
- 24.5 CYNOSURE
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
- 24.5.3 KEY STRATEGIES
- 24.5.4 KEY STRENGTHS
- 24.5.5 KEY OPPORTUNITIES
- 24.6 EL.EN. S.P.A.
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERINGS
- 24.6.3 KEY STRATEGIES
- 24.6.4 KEY STRENGTHS
- 24.6.5 KEY OPPORTUNITIES
- 24.7 GALDERMA
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
- 24.7.3 KEY STRATEGIES
- 24.7.4 KEY STRENGTHS
- 24.7.5 KEY OPPORTUNITIES
- 24.8 JOHNSON & JOHNSON
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
- 24.8.3 KEY STRATEGIES
- 24.8.4 KEY STRENGTHS
- 24.8.5 KEY OPPORTUNITIES
- 24.9 LUMENIS
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 PRODUCT OFFERINGS
- 24.9.3 KEY STRATEGIES
- 24.9.4 KEY STRENGTHS
- 24.9.5 KEY OPPORTUNITIES
- 24.10 MERZ PHARMA
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 PRODUCT OFFERINGS
- 24.10.3 KEY STRATEGIES
- 24.10.4 KEY STRENGTHS
- 24.10.5 KEY OPPORTUNITIES
- 24.11 SIENTRA
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 PRODUCT OFFERINGS
- 24.11.3 KEY STRATEGIES
- 24.11.4 KEY STRENGTHS
- 24.11.5 KEY OPPORTUNITIES
- 24.12 SINCLAIR
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERINGS
- 24.12.3 KEY STRATEGIES
- 24.12.4 KEY STRENGTHS
- 24.12.5 KEY OPPORTUNITIES
- 24.13 SISRAM MEDICAL
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 PRODUCT OFFERINGS
- 24.13.3 KEY STRATEGIES
- 24.13.4 KEY STRENGTHS
- 24.13.5 KEY OPPORTUNITIES
- 25 OTHER PROMINENT VENDORS
- 25.1 AEROLASE
- 25.1.1 BUSINESS OVERVIEW
- 25.1.2 PRODUCT OFFERINGS
- 25.2 AESTHETICS BIOMEDICAL
- 25.2.1 BUSINESS OVERVIEW
- 25.2.2 PRODUCT OFFERINGS
- 25.3 ASCLEPION LASER TECHNOLOGIES
- 25.3.1 BUSINESS OVERVIEW
- 25.3.2 PRODUCT OFFERINGS
- 25.4 ASTANZA LASER
- 25.4.1 BUSINESS OVERVIEW
- 25.4.2 PRODUCT OFFERINGS
- 25.5 BEIJING SANHE BEAUTY S & T CO.
- 25.5.1 BUSINESS OVERVIEW
- 25.5.2 PRODUCT OFFERINGS
- 25.6 BEIJING ADSS DEVELOPMENT
- 25.6.1 BUSINESS OVERVIEW
- 25.6.2 PRODUCT OFFERINGS
- 25.7 BIOLITEC
- 25.7.1 BUSINESS OVERVIEW
- 25.7.2 PRODUCT OFFERINGS
- 25.8 BIOTEC ITALIA
- 25.8.1 BUSINESS OVERVIEW
- 25.8.2 PRODUCT OFFERINGS
- 25.9 BISON MEDICAL
- 25.9.1 BUSINESS OVERVIEW
- 25.9.2 PRODUCT OFFERINGS
- 25.10 BLUECORE COMPANY
- 25.10.1 BUSINESS OVERVIEW
- 25.10.2 PRODUCT OFFERINGS
- 25.11 BRERA MEDICAL TECHNOLOGIES S.R.L.
- 25.11.1 BUSINESS OVERVIEW
- 25.11.2 PRODUCT OFFERINGS
- 25.12 BTL AESTHETICS
- 25.12.1 BUSINESS OVERVIEW
- 25.12.2 PRODUCT OFFERINGS
- 25.13 CARTESSA AESTHETICS
- 25.13.1 BUSINESS OVERVIEW
- 25.13.2 24.15.2 PRODUCT OFFERINGS
- 25.14 DOMINION AESTHETIC TECHNOLOGIES
- 25.14.1 BUSINESS OVERVIEW
- 25.14.2 PRODUCT OFFERINGS
- 25.15 ERCHONIA
- 25.15.1 BUSINESS OVERVIEW
- 25.15.2 PRODUCT OFFERINGS
- 25.16 ENDYMED
- 25.16.1 BUSINESS OVERVIEW
- 25.16.2 PRODUCT OFFERINGS
- 25.17 F CARE SYSTEMS
- 25.17.1 BUSINESS OVERVIEW
- 25.17.2 PRODUCT OFFERINGS
- 25.18 GIGAALASER
- 25.18.1 BUSINESS OVERVIEW
- 25.18.2 PRODUCT OFFERINGS
- 25.19 GSD - GLOBAL SKIN DERMATOLOGIST
- 25.19.1 BUSINESS OVERVIEW
- 25.19.2 PRODUCT OFFERINGS
- 25.20 INMODE AESTHETIC SOLUTIONS
- 25.20.1 BUSINESS OVERVIEW
- 25.20.2 PRODUCT OFFERINGS
- 25.21 LEAFLIFE TECHNOLOGY
- 25.21.1 BUSINESS OVERVIEW
- 25.21.2 PRODUCT OFFERINGS
- 25.22 LINLINE MEDICAL SYSTEMS
- 25.22.1 BUSINESS OVERVIEW
- 25.22.2 PRODUCT OFFERINGS
- 25.23 LUTRONIC
- 25.23.1 BUSINESS OVERVIEW
- 25.23.2 PRODUCT OFFERINGS
- 25.24 LYNTON LASERS
- 25.24.1 BUSINESS OVERVIEW
- 25.24.2 PRODUCT OFFERINGS
- 25.25 MEDART APS
- 25.25.1 BUSINESS OVERVIEW
- 25.25.2 PRODUCT OFFERINGS
- 25.26 MICROAIRE SURGICAL INSTRUMENTS
- 25.26.1 BUSINESS OVERVIEW
- 25.26.2 PRODUCT OFFERINGS
- 25.27 MEDYTOX
- 25.27.1 BUSINESS OVERVIEW
- 25.27.2 PRODUCT OFFERINGS
- 25.28 MEYER-HAAKE
- 25.28.1 BUSINESS OVERVIEW
- 25.28.2 PRODUCT OFFERINGS
- 25.29 PHOTOMEDEX
- 25.29.1 BUSINESS OVERVIEW
- 25.29.2 PRODUCT OFFERINGS
- 25.30 REVANCE AESTHETICS
- 25.30.1 BUSINESS OVERVIEW
- 25.30.2 PRODUCT OFFERINGS
- 25.31 SCITON
- 25.31.1 BUSINESS OVERVIEW
- 25.31.2 PRODUCT OFFERINGS
- 25.32 THERMIGEN
- 25.32.1 BUSINESS OVERVIEW
- 25.32.2 PRODUCT OFFERINGS
- 25.33 VENUS CONCEPT
- 25.33.1 BUSINESS OVERVIEW
- 25.33.2 PRODUCT OFFERINGS
- 25.34 WAVEMED
- 25.34.1 BUSINESS OVERVIEW
- 25.34.2 PRODUCT OFFERINGS
- 25.35 ZIMMER MEDIZINSYSTEME
- 25.35.1 BUSINESS OVERVIEW
- 25.35.2 PRODUCT OFFERINGS
- 26 REPORT SUMMARY
- 26.1 KEY TAKEAWAYS
- 26.2 STRATEGIC RECOMMENDATIONS
- 27 QUANTITATIVE SUMMARY
- 27.1 MARKET BY GEOGRAPHY
- 27.2 MARKET BY PROCEDURE
- 27.3 MARKET BY PRODUCTS
- 27.4 MARKET BY APPLICATIONS
- 27.5 MARKET BY END USER
- 27.6 MARKET BY PROCEDURE: BY REGION
- 27.6.1 NORTH AMERICA: MARKET BY PROCEDURE
- 27.6.2 EUROPE: MARKET BY PROCEDURE
- 27.6.3 APAC: MARKET BY PROCEDURE
- 27.6.4 LATIN AMERICA: MARKET BY PROCEDURE
- 27.6.5 MIDDLE EAST & AFRICA: MARKET BY PROCEDURE
- 27.7 MARKET BY PRODUCTS: BY REGION
- 27.7.1 NORTH AMERICA: MARKET BY PRODUCT
- 27.7.2 EUROPE: MARKET BY PRODUCT
- 27.7.3 APAC: MARKET BY PRODUCT
- 27.7.4 LATIN AMERICA: MARKET BY PRODUCT
- 27.7.5 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
- 27.8 MARKET BY APPLICATION: BY REGION
- 27.8.1 NORTH AMERICA: MARKET BY APPLICATION
- 27.8.2 EUROPE: MARKET BY APPLICATION
- 27.8.3 APAC: MARKET BY APPLICATION
- 27.8.4 LATIN AMERICA: MARKET BY APPLICATION
- 27.8.5 MIDDLE EAST & AFRICA: MARKET BY APPLICATION
- 27.9 MARKET BY END USER: BY REGION
- 27.9.1 NORTH AMERICA: MARKET BY END USER
- 27.9.2 EUROPE: MARKET BY END USER
- 27.9.3 APAC: MARKET BY END USER
- 27.9.4 LATIN AMERICA: MARKET BY END USER
- 27.9.5 MIDDLE EAST & AFRICA: MARKET BY END USER
- 28 APPENDIX
- 28.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
